Neil H. Riordan, Maria Luisa Hincapié, Isabela Morales, Giselle Fernandez, Nicole Allen, Cindy Leu, Marialaura Madrigal, Jorge Paz Rodriguez, Nelson Navarro First published: 11 June 2019 https...
Okur SÇ 1, Erdoğan S 2, Demir CS 3, Günel G 3, Karaöz E 2,3,4. AUTHOR INFORMATION: 1 Department of Physical Therapy and Rehab, Health Science University, Bakirköy Dr Sadi Konuk Traini...
Neil Riordan, PA, PhD presented “Results From Panama Clinical Trials Using Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (HUCT-MSCs) for Multiple Sclerosis and Autism” at the 5th...
https://www.cellmedicine.com/wp-content/uploads/2019/01/Top-10-600×285.jpeg Congratulations to Dr. Riordan and everyone at Stem Cell Institute and Medistem Labs in Panama! Multiple Sclerosis...
Go to Original Post on RickJaffe.com Today was a good day for people who want continued access stem cells outside of clinic trials, and also for people who want the FDA to allow faster access to ...
The first patient with Duchenne Muscular Dystrophy to be granted FDA approval for allogeneic adult stem cell therapy in the United States turned 30 this year, well surpassing his original life ex...
Neil Riordan, PhD speaks at the Riordan-McKenna Institute and Stem Cell Institute fall seminar in Southlake, Texas on October 10, 2015. Dr. Riordan discusses: How our lab selects uses specialized...
Stem Cell Institute and Medistem Panama founder, Neil Riordan, PhD discusses clinical trials for multiple sclerosis and rheumatoid arthritis using umbilical cord tissue-derived mesenchymal stem c...
The Stem Cell Institute, located in Panama City, Panama, will present an informational seminar about umbilical cord stem cell therapy on Saturday, September 20, 2014 in San Antonio, Texas at the ...
Ryan Benton, a 28 year-old Duchenne’s muscular dystrophy patient from Wichita, Kansas, received his first umbilical cord tissue-derived mesenchymal stem cell treatment yesterday at Asthma and A...